Skip to main content

The Old Reality is Still the New Reality


The Old Reality is Still the New Reality



Dodd Frank Illustration

 
I sat at my desk last week wondering what went wrong. Was I experiencing some type of trading depression? I checked my models, macro numbers, company profits, software, pricing etc. Some of my option contracts were either worthless or were on their way to being worthless.
 
The pricing of the contracts were not in-line with the actual underlying price of the securities that I was trading. The options' pricing per contract were either priced 40% or more above what the underlying security was worth or priced 40% or more below what the securities were worth.

This old reality was still the new reality even after all of financial fixes implemented to fix these same problems that contributed to the financial meltdown in 2007-2008.  The new Dodd-Frank Wall Street Reform and ConsumerProtection Act which was supposed to clean up many of the abuses in the financial system such as accountability, transparency and pricing unfortunately is not working.

Sophisticated computer driven algorithms, trading groups arbitraging on different exchanges, unregulated billions in dark pools of money trading silently in the background from undisclosed traders, lax oversight of the Options Clearing Houses are still causing a nasty mix of asset mispricing, and investor angst, especially in the options and derivative markets here in the U.S..

Mispricing of assets costs everyone, especially small investors billions in dollars daily. It prevents, many whom may want to invest from not investing due to fear; it contributes to misallocation of investors’ money from flowing to real companies to instead flow to zombie or otherwise bankrupt entities’ and finally it contributes to financial fraud on such a large scale that regulators may seem overwhelmed or incapable of tackling the problem.

I am proposing tougher regulation with teeth, not less, that will help alleviate asset mispricing. So that small investors like myself can confidently make better decisions in the financial markets without being fleeced of our hard-earned money.
 
By Rick Walter

Write to Rick Walter at invest@ucsinv1.com

Comments

Popular posts from this blog

Morning Update

By Rick Walter Still working on putting together a strong biotech portfolio. Here is a good general article on the state of the biotech industry that was posted yesterday on the online Wall Street Journal's site- Biotech Stocks Hot Right Now, Ho-Hum in the Long Run.

Portfolio Update

By Rick Walter I have posted a new Biotechnology portfolio . It's total return as of November 25, 2009 is 3.4%. However, to download and use it you will have to subscribe to the portfolio, of course. On an important note, I consider each portfolio to be well diversified in its particular sector but I've recently decided to add stock futures and options positions to each portfolio which will increase each portfolio's return but lower the risks going forward.

Biotech Pump and Dump

By Rick Walter Building a good Biotechnology portfolio has turned out to be a bit of a task. I have one on the table, but feel that it's a little too aggressive and risky, especially for today's market. Funding for most Biotech ventures- old or new, have either dried up or have been put on hold. This portfolio that I am building is too much of a pure Biotech play. It would be feast or famine on the returns. Let me explain. I remember when I was a young broker, I worked for this small outfit in Florida where the office manager and a few other brokers, including myself, would get all pumped up over a stock called Celi. I believe that the stock is now trading on the Amex as (Cel-Sci: CVM ). Well the stock was always on the verge of getting approval for some phase of cancer treatment therapy. Whenever the company released news, we would run the stock up as high as the market makers would let us run it- ($1.30 to $2.30 per share) before we banged it back down to previous lows of .30...